182 related articles for article (PubMed ID: 31950578)
1. Single-molecule detection of cancer mutations using a novel PCR-LDR-qPCR assay.
Ruiz C; Huang J; Giardina SF; Feinberg PB; Mirza AH; Bacolod MD; Soper SA; Barany F
Hum Mutat; 2020 May; 41(5):1051-1068. PubMed ID: 31950578
[TBL] [Abstract][Full Text] [Related]
2. Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA.
Wood-Bouwens C; Lau BT; Handy CM; Lee H; Ji HP
J Mol Diagn; 2017 Sep; 19(5):697-710. PubMed ID: 28818432
[TBL] [Abstract][Full Text] [Related]
3. [Detection of KRAS gene mutation and its clinical significance in colorectal adenocarcinoma].
Xu C; Liu YL; Huang J; He DM; Hou YY; Ji Y; Hou J; Lu SH; Xu JF; Hu Q; Shi Y; Zhao LJ; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):667-70. PubMed ID: 23302307
[TBL] [Abstract][Full Text] [Related]
4. Wobble-enhanced ARMS method for detection of KRAS and BRAF mutations.
Hamfjord J; Stangeland AM; Skrede ML; Tveit KM; Ikdahl T; Kure EH
Diagn Mol Pathol; 2011 Sep; 20(3):158-65. PubMed ID: 21817902
[TBL] [Abstract][Full Text] [Related]
5. An enzymatic on/off switch-mediated assay for KRAS hotspot point mutation detection of circulating tumor DNA.
Wang QL; Zhou CL; Yin YF; Xiao L; Wang Y; Li K
J Clin Lab Anal; 2020 Aug; 34(8):e23305. PubMed ID: 32207862
[TBL] [Abstract][Full Text] [Related]
6. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
Thierry AR
Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
[TBL] [Abstract][Full Text] [Related]
7. Clinical validation of qPCR Target Selector™ assays using highly specific switch-blockers for rare mutation detection.
Arnold L; Alexiadis V; Watanaskul T; Zarrabi V; Poole J; Singh V
J Clin Pathol; 2020 Oct; 73(10):648-655. PubMed ID: 32132121
[TBL] [Abstract][Full Text] [Related]
8. KRas and BRaf mutational status analysis from formalin-fixed, paraffin-embedded tissues using multiplex polymerase chain reaction-based assay.
Jakubauskas A; Griskevicius L
Arch Pathol Lab Med; 2010 Apr; 134(4):620-4. PubMed ID: 20367313
[TBL] [Abstract][Full Text] [Related]
9. Serial processing of biological reactions using flow-through microfluidic devices: coupled PCR/LDR for the detection of low-abundant DNA point mutations.
Hashimoto M; Barany F; Xu F; Soper SA
Analyst; 2007 Sep; 132(9):913-21. PubMed ID: 17710267
[TBL] [Abstract][Full Text] [Related]
10. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
[TBL] [Abstract][Full Text] [Related]
11. Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification.
Itonaga M; Matsuzaki I; Warigaya K; Tamura T; Shimizu Y; Fujimoto M; Kojima F; Ichinose M; Murata S
PLoS One; 2016; 11(3):e0151654. PubMed ID: 26999437
[TBL] [Abstract][Full Text] [Related]
12. Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.
Huang JF; Zeng DZ; Duan GJ; Shi Y; Deng GH; Xia H; Xu HQ; Zhao N; Fu WL; Huang Q
PLoS One; 2015; 10(12):e0145698. PubMed ID: 26701781
[TBL] [Abstract][Full Text] [Related]
13. Selective amplification of rare mutations using locked nucleic acid oligonucleotides that competitively inhibit primer binding to wild-type DNA.
Oldenburg RP; Liu MS; Kolodney MS
J Invest Dermatol; 2008 Feb; 128(2):398-402. PubMed ID: 17581615
[TBL] [Abstract][Full Text] [Related]
14. Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay.
Lyu N; Rajendran VK; Diefenbach RJ; Charles K; Clarke SJ; Engel A; ; Rizos H; Molloy MP; Wang Y
Nanotheranostics; 2020; 4(4):224-232. PubMed ID: 32923312
[TBL] [Abstract][Full Text] [Related]
15. Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
Liebs S; Keilholz U; Kehler I; Schweiger C; Haybäck J; Nonnenmacher A
Cancer Med; 2019 Jul; 8(8):3761-3769. PubMed ID: 31134762
[TBL] [Abstract][Full Text] [Related]
16. Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection.
Bacolod MD; Huang J; Giardina SF; Feinberg PB; Mirza AH; Swistel A; Soper SA; Barany F
BMC Cancer; 2020 Jan; 20(1):85. PubMed ID: 32005108
[TBL] [Abstract][Full Text] [Related]
17. T-blocker: a simple and robust probe-free quantitative PCR assay to detect somatic mutations down to 0.1% frequency.
Kim H; Ruby AE; Shandilya HG; Virmani AK; Rahman N; Strange CM; Huuskonen J
Biotechniques; 2018 Oct; 65(4):205-210. PubMed ID: 30284934
[TBL] [Abstract][Full Text] [Related]
18. Multiplex Detection of KRAS Mutations Using Passive Droplet Fusion.
Pekin D; Taly V
Methods Mol Biol; 2017; 1547():133-142. PubMed ID: 28044293
[TBL] [Abstract][Full Text] [Related]
19. Development and Clinical Validation of Discriminatory Multitarget Digital Droplet PCR Assays for the Detection of Hot Spot KRAS and NRAS Mutations in Cell-Free DNA.
Hussung S; Follo M; Klar RFU; Michalczyk S; Fritsch K; Nollmann F; Hipp J; Duyster J; Scherer F; von Bubnoff N; Boerries M; Wittel U; Fritsch RM
J Mol Diagn; 2020 Jul; 22(7):943-956. PubMed ID: 32376474
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.
Franczak C; Witz A; Geoffroy K; Demange J; Rouyer M; Husson M; Massard V; Gavoille C; Lambert A; Gilson P; Gambier N; Scala-Bertola J; Merlin JL; Harlé A
PLoS One; 2020; 15(1):e0227294. PubMed ID: 31940389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
